Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation

Br J Haematol. 2023 May;201(4):725-737. doi: 10.1111/bjh.18574. Epub 2022 Dec 5.

Abstract

Dysbiosis of the gut microbiota has been reported to increase early complications after allogeneic haematopoietic stem cell transplantation (allo-HSCT). However, it remains unclear whether gut microbial alterations persist during late complications, such as chronic graft-versus-host disease (cGVHD) or secondary cancers. Here, we analysed the gut microbiota of 59 patients who survived for 1-21.7 years (median, 6.4 years) after allo-HSCT. Long-term survivors showed lower gut microbial diversity than the age- and sex-matched healthy controls. This decreased diversity was reflected in the reduced abundance of the butyrate-producing bacteria. Patients with a history of grade 3 acute graft-versus-host disease (aGVHD) exhibited higher Veillonella abundance than patients with a history of grade 1-2 or non-aGVHD cases. The abundance of Faecalibacterium showed no decrease only in limited cGVHD cases. Additionally, the microbial structure in the secondary cancer group was significantly different (p < 0.05) from that in the non-secondary cancer group. This study is the first to show that microbial dysbiosis is present over a 10-year lifetime after discharge following allo-HSCT. Our results suggest that these prolonged gut microbial alterations may be associated with the development and exacerbation of late complications in post-transplant survivors.

Keywords: aGVHD; allogeneic haematopoietic stem cell transplantation; cGVHD; gut microbiota; second cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchiolitis Obliterans Syndrome*
  • Dysbiosis / complications
  • Gastrointestinal Microbiome*
  • Graft vs Host Disease* / microbiology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Patient Discharge